Re: Singh A et al . Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9

[1] on the safety and feasibility of robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in testicular cancer patients with postchemotherapy residual mass. [5] reported the overall incidence of chyle leak as 7% in O-RPLND for postchemotherapy residual mass. [...]the safety of RA-RPLND cannot be superior and we believe that the best inferences on safety and efficacy of RA-RPLND may be derived in a study comparing it with O-RPLND. Robot-assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor.